According to Zhitong Finance App, Tianyu Co., Ltd. (300702.SZ) issued an announcement. Zhejiang Nuode Pharmaceutical Co., Ltd. (“Nuode Pharmaceutical”), a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for tigliptin hydrobromide tablets approved and issued by the State Drug Administration. The drug's indications are: Single drug treatment: This product can be used with diet control and exercise to improve blood sugar control in adult type 2 diabetics.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.